In order to protect their businesses, nutraceutical companies need to have certain protective documents in place prior to or promptly at the beginning of any dealings with potential new employees and investors. In his byline on www.nutraingredients-usa.com, Foley’s Thomas James discusses the various types of documents that are vital to a nutraceutical company’s protection and potential ramifications of not utilizing these documents.
Click here for the full article.
Click here for the full article.
Related Insights
21 March 2025
Foley Ignite
A Delay in Exit Plans
There was much hope going into 2025 that we would see a rebound in the IPO market after a bit of a drought over the past few years. We left the uncertainty of the election behind us, and good news on the inflation and interest rate fronts were fueling a sense of hope that 2025 was going to be a great year for the IPO market.
30 April 2025
Events
Private Equity and Health Care – A Policy Discussion
Foley partner Larry Vernaglia, co-chair of the firm’s Providers of Health Care Services Area of Focus, and senior counsel Allie Shalom, co-chair of the firm’s Payor/Provider Convergence Area of Focus, are speaking in Healthcare Financial Management Association’s upcoming webinar titled “Private Equity and Health Care – A Policy Discussion” on April 30.
03 May 2025
Events
American Telemedicine Association Nexus 2025
Foley is proud to continue its sponsorship of the American Telemedicine Association (ATA) to offer a plethora of industry insights with attendees during ATA Nexus 2025, exploring The Next Chapter in Virtual Care.